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Abstract
Herpes simplex encephalitis (HSE) is a rare complication of Herpes simplex virus type-1
infection. It results in severe parenchymal damage in the brain. Although viral latency in
neurons is very common in the population, it remains unclear why certain individuals
develop HSE. Here we explore potential host genetic variants predisposing to HSE. In order
to investigate this we used a rat HSE model comparing the HSE susceptible SHR (Sponta-
neously Hypertensive Rats) with the asymptomatic infection of BN (Brown Norway). Nota-
bly, both strains have HSV-1 spread to the CNS at four days after infection. A genome wide
linkage analysis of 29 infected HXB/BXH RILs (recombinant inbred lines—generated from
the prior two strains), displayed variable susceptibility to HSE enabling the definition of a
significant QTL (quantitative trait locus) named Hse6 towards the end of chromosome 4
(160.89–174Mb) containing the Vwf (von Willebrand factor) gene. This was the only gene in
the QTL with both cis-regulation in the brain and included several non-synonymous SNPs
(single nucleotide polymorphism). Intriguingly, in human chromosome 12 several SNPs
within the intronic region between exon 43 and 44 of the VWF gene were associated with
human HSE pathogenesis. In particular, rs917859 is nominally associated with an odds
ratio of 1.5 (95% CI 1.11–2.02; p-value = 0.008) after genotyping in 115 HSE cases and 428
controls. Although there are possibly several genetic and environmental factors involved in
development of HSE, our study identifies variants of the VWF gene as candidates for sus-
ceptibility in experimental and human HSE.
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Introduction
HSV-1 (Herpes simplex virus type-1) infects the majority of the population resulting in tran-
sient cold sores or asymptomatic infection which persists lifelong in the sensory ganglia of the
infected individuals. Recurrent herpetic disease occurs after reactivation of HSV-1 from latency
in sensory neurons and axonal transport to the periphery. Even though HSV-1 is a widely
spread neurotropic virus, herpes simplex encephalitis (HSE) occurs in only 2–3 individuals/
million/year and in all ages [1]. More than ninety percent of HSE cases are caused by HSV
type-1 and the rest by HSV type-2 [2]. The virus may reach the fronto-temporal lobe via the
olfactory tract during primary infection or, more commonly via the trigeminal ganglion after
reactivation, resulting in acute aggressive focal necrotizing encephalitis. Patients classically
present with fever, headache, altered consciousness, confusion, personality changes, seizures,
temporal lobe haemorrhaging and/or other symptoms of focal neurological damage [3, 4]. The
disease has a tendency to relapse or have a progressive course [5]. Despite acyclovir treatment,
the mortality remains high (6–15%) and among the survivors a high risk of persisting neuro-
logical and cognitive deficits remains [6].
We have previously established a rat model of HSE by injecting HSV-1 unilaterally into the
whiskers area of inbred DA (Dark Agouti) rats [7]. The in vivomodel resembles in several
aspects the viral spread in human disease, starting from the whiskers area of the rats, corre-
sponding to the labio-facial area in humans. The virus penetrates the peripheral nerve fascicles,
spreads then to the trigeminal ganglion, subsequently to the ipsilateral side of the brain stem
and then spreads contra-laterally and anteriorly. From 2 dpi (days post-infection) HSV-1 repli-
cates in the perineural cell layer surrounding nerve bundles in the whiskers area [8]. In a model
of resistance to HSE, we found that inbred PVG (Piebald Virol Glaxo) rats did not develop
HSE because the virus fails to penetrate into the trigeminal nerve. Thus, in PVG rats the CNS
(central nervous system) remains uninfected and protected from immunological consequences
[7]. We have previously identified the calcitonin receptor gene (Calcr) as a candidate for viral
spread regulation into the CNS in a F2 (DAxPVG.A) intercross [9]. However, in this study we
use different rat strains, HSE susceptible SHR (Spontaneously Hypertensive Rats) and asymp-
tomatic infected BN (Brown Norway), that both have viral spread to the nervous system to
explore the genetic factors behind HSE development, regardless of the presence of virus in the
CNS.
The factors rendering certain hosts; rodents or humans, susceptible to HSE remain unclear.
We hypothesized that several variants within the host genome may play a role. Thus, the aims
of the present study were to investigate and map any genetic contribution in a rat HSE model
and further study the relevance of the findings to human HSE. We identified a genomic region
on rat chromosome 4 (Hse6) regulating susceptibility vs. resistance to HSE using linkage analy-
sis, gene expression in the HXB/BXH RILs (recombinant inbred lines—generated from the
prior two strains) [10] and genome sequence analyses in parental strains. The Vwf gene was
identified as the main candidate gene regulating rat HSE in this set of strain combinations.




All animal experiments in this study were performed in accordance with the guidelines from
the Swedish National Board for Laboratory Animals and the European Community Council
Directive (86/609/EEC) and approved by the Swedish ethical committee (Stockholm’s North
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Ethical Committee—Stockholms Norra Djurförsöksetiska Nämnd) (ethical permit N340/08).
Additionally, all human studies enrolment followed the recommendations of the Declaration
of Helsinki and the Ethics Committee of the Karolinska Institutet approved the study. Oral and
written information was given to the patients and confirmed consent in writing was received
before inclusion. (Ethical permit numbers 2002–548, 2004/1-4:6, 2006/1:7, 2008/2:9, 2009/
2107-31/2 and 2012/756-31/1).
Animals
Rats of two inbred strains: the normotensive Brown Norway (BN.Lx) and the Spontaneously
Hypertensive Rats (SHR/Ola) were used and 29 RILs (recombinant inbred lines; HXB and
BXH). The HXB/BXH sets of RILs (n = 29) were derived from F2 rats obtained by reciprocal
crossings of the Spontaneously Hypertensive Rats (SHR/Ola) and the Brown Norway (BN.Lx/
Cub) strains [10] followed by brother x sister inbreeding for over 60 generations. The two
inbred rats strains and RILs were bred in Prague (Dr. Michal Pravenec’s laboratory) and
imported to Karolinska Institutet one week before the experiments were performed. In this
article we refer to the parental strains as BN and SHR for convenience.
We used male rats of parental strains BN, SHR, as well as of 19 HXB and 10 BXH RILs. All
rats were 45 days old when infected with HSV-1. After infection the rats were observed and fol-
lowed twice a day for phenotype development until humane endpoint/death or latest until 11
dpi (experimental end point). We defined susceptibility as all rats of a strain reaching a point
of no return before dying or dying from HSE and resistance as all rats of a strain being symp-
tom-free and surviving. To detect preclinical signs of disease all rats were weighed daily and
examined to detect possible symptoms of HSE development. Animal suffering was minimized
by adding extra enrichments, diet pellets on the bedding. However, no pain relievers could be
used, since they would have influenced the progression of inflammation. Nevertheless, due to
the quick development of the first clinical symptoms to the humane endpoint, the animal suf-
fering in this model was restricted to less than a day. Humane endpoint was defined as a fully
developed encephalitis with a point of no return, i.e. when the rats were lying on their side
without being able to stand up or crawl. Animals were euthanized using an overdose of
barbiturate.
Additional strains were used for haplotype mapping, i.e. Fisher 344 rats (F344: 5 females, 5
males) generously provided by Professor Holger Luthman, Lund University (Sweden); Lewis
rats (LEW: 3 females, 7 males); and spontaneously type 1 diabetic Bio Breeding rats (BB: 1
female, 1 male) from in house breeding [9].
During the experiment rats were kept in a full-barrier animal facility at Portalen Nord, the
laboratory animal import station of Karolinska Institutet in groups of 3 to 5 animals per cage
under specific pathogen-free and climate-controlled conditions, with 12 hours light/dark
cycles. The rats were housed in Eurotype IV cages, in stainless steel isolators (Decco Steel, Swe-
den) containing aspen wood chips, shavings and chew blocks (Tapvei, Finland) and fed stan-
dard rodent chow (SDS, England) and water ad libitum. Ambient temperature was 21°C.
Virus
HSV-1 virus strain I-2762 used was isolated from a brain biopsy taken from a male patient on
day 2 after onset of the first clinical symptoms of HSE as described previously [7, 8]. After
being thawed to room temperature, 100μl virus suspensions, containing 2 x 106 PFU HSV-1
were injected subcutaneously (s.c.) into the area of the whiskers’ base unilaterally, on the right
side, under 2% Isoflurane (Baxter) anesthesia.
VWFGene Regulates HSE
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Immunohistochemistry
Five rats of each parental strain BN and SHR were used for immunohistochemistry and mini-
mum three sections per rat were evaluated from each tissue; whiskers area, trigeminal ganglia
and brain stem. The method used for tissue preparation, staining and antibodies were
described previously [8]. The antibodies used include polyclonal rabbit anti-HSV-1 (1:100)
(Dako), mouse monoclonal anti-Tuj1 (1:500) (Covance), mouse monoclonal anti-ED1 (1:200)
(Serotec), mouse monoclonal anti-NKRp1 (1:200) (Harlan Sea-Lab) and mouse monoclonal
anti-CD8 (1:200) (Serotec). Additional antibodies used in this study include; polyclonal rabbit
anti-von Willebrand factor Ab (1:200) (Abcam) to visualize vWF in the endothelial cell layer
and mouse monoclonal anti-Occludin 1A8 Ab (1:200) (Antibodies Online) to visualize the
expression of tight junction proteins. After incubation with primary antibodies, sections were
rinsed and incubated with Alexa Fluor™1488 goat anti-rabbit (1:200) (Molecular Probes, USA)
or Alexa Fluor™1 594 goat anti-mouse (1:200) (Molecular Probes) secondary antibodies.
Micrographs were taken on a Zeiss Axioskop microscope system and processed in Adobe Pho-
toshop CS3. The pictures included in the Figs represent the staining differences visualised in all
slides from the different compartments of all the rats studied.
QTL Linkage analysis of RILs
QTL linkage analysis correlates the genotypes of each RIL at discrete chromosomal markers
with a quantitative phenotype, in this case, incidence of HSE, onset of symptoms, survival days
and median weight loss between d0–10 dpi. If there is a strong association between the differ-
ences in phenotype and a certain genotype, a QTL will be detected [11]. For the QTL linkage
analysis presented in the results section we used median values for all studied phenotypes;
these values are summarized in (Fig 3). However, due to some variation in the phenotypes
measured for some RILs we also run the linkage analysis including these lines as an intermedi-
ate phenotype and they all gave the same QTLs (data not shown, Fig 3). Additionally, we also
run the analysis using calculated mean values for all measured phenotypes and these also gave
the exact same QTLs (data not shown).
We report loci with genome-wide significance and those considered suggestive are based on
1000 permutation tests that randomly reassign [permute] trait values across the lines and give
the thresholds for QTL significance. Whole genome linkage maps were generated using con-
ventional interval mapping allowing linkage analysis across the genome even at points where
the genotype data were sparse. Trait values were compared with the probability that a specific
genotype exists at a specified location. The LRS (likelihood ratio statistic), a chi-square statistic,
provides a measure of the linkage between variation in the phenotype and genetic differences
at a specific genetic locus, used to identify genome-wide significant QTLs. LOD (logarithm of
odds) values can be obtained by dividing the LRS values by 4.6. All linkage maps were gener-
ated using WebQTL (The GeneNetwork: http://www.genenetwork.org) and bootstrap analysis
was used to evaluate the approximate confidence intervals of QTL peaks.
Bioinformatic and eQTL analysis
Genome-wide expression data of 15,923 transcripts was previously collected from fat and kid-
ney of 30 RI strains and the SHR and BN progenitor [12] and over 30,000 transcripts from
adrenal, kidney, aorta, left ventricle, liver and skeletal muscle [13]. In addition, brain expres-
sion data was collected for 198,796 genome-wide transcript clusters (both known/annotated
transcripts and computationally predicted transcripts) using the Affymetrix Rat Exon 1.0 ST
array. We defined a cis-acting eQTL as a linkage peak for transcript expression within 10 Mbp
of the physical location of the transcript. The cis-eQTLs in theHse6 (chromosome 4: 160.89
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Mb to 174 Mb) were extracted using eQTL explorer [14, 15] and the PhenoGen website (http://
phenogen.ucdenver.edu; [16]). All eQTLs were calculated with the HXB/BXH panel of recom-
binant inbred rats using an Affymetrix microarray platform. A small proportion of the eQTLs
were detected independently in more than one tissue. These eQTLs can be considered repli-
cated linkages and may reflect common regulatory mechanisms that are shared between
tissues.
The genomic SNP variants identified in the SHR and BN strain within theHse6 region were
extracted using the database SHR base (http://shr.csc.mrc.ac.uk/index.cgi) [17]. To evaluate an
eventual functional effect of the variants in the BN genome with respect to their location in
annotated genes (ENSEMBL64), ENSEMBL perl APIs database was used. The primer
sequences used for Vwf SNPs validation in rat using capillary sequencing included the three
primers: (Chr.4 position: 161,784,105) forward primer CCTGATGGTCACTGATGGTGAT and
reverse primer ACACCGGCGTGTATCAGATG; (position: 161,741,472) forward primer
TTGTGTCTGTCCCTCTGACCAT and reverse primer AGTGTGTACCAACCTGCTGCAT; (posi-
tion: 161,724,332) forward primer TTATTGTCATGAGTCTGGGGTCA and reverse primer CAG
GACTCACCGAGAATTGAGA. The SNP haplotype map was generated in RGD (rat genome
database).
Western Blot
Frozen tissue samples from 4 naïve BN and SHR rats were suspended in RIPA buffer (Sigma,
R0278) supplemented with Complete1 protease inhibitors (Roche). The samples were solubi-
lized by shaking with metal beads (10 min, 50/s) and subsequently sonicated (10 min, 30s on/
off). The lysates were cleared by centrifugation (13000 rpm, 4°C, 15 min) to retrieve the pro-
tein-containing supernatants. Protein concentrations were determined using the BCA assay
(Pierce).
Samples (40μg) were boiled in reducing Laemmli dye (95°C, 5 min) and separated by
SDS-PAGE 4–20% MiniPROTEAN1 TGX™ precast gels (BioRad). After wet transfer to
HyBond-ECL nitrocellulose membranes (GE-healthcare), the membranes were blocked using
Odyssey1 PBS-based Blocking Buffer (LiCOR) and split at the 70kDa marker. The upper part
was incubated with polyclonal rabbit anti-vWF (H-300) (Santa Cruz, sc-14014), while the
lower part was incubated with polyclonal rabbit anti-Actin (Sigma, A2066) (o.n. 4°C). Mem-
branes were washed 3x with 0.05% PBS-Tween20 and incubated with donkey anti-rabbit
IRDye1 800CW (LiCOR) (1h, RT). Unbound antibody was removed by washing 3x with
0.05% PBS-Tween20 and 2x with PBS. Membranes were scanned and quantified using the
Odyssey1 Clx system (LiCOR).
Human HSE and controls cohorts
The HSE patients were recruited nation-wide through the national registries using the unique
personal identity number following approval of ethical review board. The initial virological
diagnosis of these HSE cases was confirmed by the detection of intrathecal HSV-1 antibody
production and PCR detection of HSV-1 DNA in CSF samples [18, 19].
The control material we used in this study consisted of a cohort used in part of another
nation-wide epidemiological study conducted at Karolinska Institutet focusing on genetic and
life-style risk factors for MS. The Epidemiology in MS (EIMS) study consists of incident cases
of MS [20]. The inclusion criteria were age between 16 and 70 years of age, recent diagnosis of
MS (within two years) and ability to understand Swedish. EIMS controls were selected from
the population registry and were matched for sex, age and region of residency. Two controls
were identified for each EIMS case. All EIMS cases and controls included in the analysis were
VWFGene Regulates HSE
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sero-positive for HSV-1 IgG as determined by ELISA at the virological laboratory, Sahlgren’s
University hospital in Gothenburg, using a whole virus HSV-1 antigen and a confirmative
HSV-1 type-specific test using IgG-1 as antigen.
The demographics of the Scandinavian HSE samples included (females n = 64 and males
n = 51; age range in years = 15–79 (9 cases<15 years); 4 non-Scandinavian HSE cases (female
n = 1 and males n = 3); Scandinavian EIMS cases (females n = 162, males n = 55; age rage in
years = 17–68); non-Scandinavian EIMS cases (females n = 23 and males n = 6); Scandinavian
EIMS controls (females n = 158, males n = 53; age rage in years = 18–70) and non-Scandina-
vian controls: (females n = 43 and males n = 8).
DNA extraction from Human HSE samples
DNA was extracted from whole blood (10–12ml) of 119 HSE cases using standard procedures
(QIAamp DNA blood maxi kit, Qiagen). DNA concentrations were measured using an ND-
1000 Spectrophotometer (NanoDrop Technologies Inc., Wilmington, DE, USA).
SNPmarkers selection and Taqman genotyping
34 SNP markers within the VWF gene were selected for genotyping by running the tagging
algorithm, implemented in Haploview 4.2 based on data from the HapMap project using r2 =
0.8 and LOD 3.0. (http://www.hapmap.org/, release R2/version3/Analysis panel CEU+TSI).
We required the tagging SNPs to be present on the Illumina Human 660-quad chip as we used
controls typed on this chip. One additional SNP (rs1860545) mapping in a nearby gene which
map in an established MS risk gene TNFRSF1A was also added.
All Scandinavian 115 HSE (4 non-Scandinavian HSE) samples and 158 EIMS (epidemiolog-
ical investigation of multiple sclerosis) project controls were genotyped using Taqman SNP
assays from Applied Biosystems (Foster City, CA, USA), as described previously [21]. Assays
for seven of the markers (rs10849376, rs216335, rs216340, rs216298, rs2283333, rs1800378 and
rs7955850) did not generate consistent genotypes or had poor success rate (<95%) and were
excluded from the analysis. Genotypes from Illumina Human660-Quad chip [22] were avail-
able for the same markers for the 217 Scandinavian (total = 246) MS cases and 211 Scandina-
vian (total = 262) population based controls from the EIMS study [20]. All 158 EIMS controls
that were genotyped with the Taqman assay had also been genotyped in the Illumina chip. The
concordance between the genotyping methods was very high. We followed up the association
to rs917859 by genotyping an additionally 6 SNPs (rs12369177, rs7301070, rs2238110,
rs917858, rs2239138, rs12829271) in the 119 HSE and 158 EIMS samples. These markers had
not been genotyped on the Illumina Human660-Quad chip.
Statistical analysis for human populations
Association of genotypes in the Scandinavian 115 HSE cases, EIMS 217 MS cases and 211 con-
trols who were positive for HSV-1 IgG was tested using the assoc and hapassoc commands in
PLINK v1.06 (http://pngu.mgh.harvard.edu/~purcell/plink/index.shtml). P-values have not
been corrected for multiple comparisons. The same analysis was performed including all indi-
viduals (Scandinavian and non-Scandinavians) 119 HSE cases and EIMS 246 MS cases and
controls. In this study we present data from both cohorts.
VWFGene Regulates HSE
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Results
HSV-1 infects the CNS of the HSE-resistant BN rats
The SHR rats developed HSE after infection with 2 x 106 PFU (plaque-forming unit) HSV-1
and died by 6 dpi. In contrast, the BN rats were clinically resistant, presenting a one day minor
weight drop around 5 dpi and thereafter continuing to gain weight corresponding to the weight
development of control rats. All BN rats survived until the end point of the experiment desig-
nated at 11 dpi and did not show any clinical symptoms of disease. Nonetheless, when previ-
ously followed for longer time period, no disease symptoms were detected in the BN rats and
they were categorized as clinically resistant.
Paraformaldehyde perfused tissue samples were taken at 4 dpi, before the onset of any
symptoms from infected BN and SHR progenitors and subjected to indirect immunohis-
tochemistry staining to visualize the presence of HSV-1, the activation of phagocytic cells
(ED1), NK-cells (NKR) and cytotoxic T-cells (CD8) in relation to the nerves in the whiskers
area, trigeminal ganglia and in the brain stem. The most striking finding was that HSV-1 pene-
trated into the trigeminal ganglia and the brain stem of both strains.
Interestingly, at 4 dpi in the whiskers area we detected the presence of HSV-1 in the epi-,
peri- and endoneurium of both BN (Fig 1A) and SHR (Fig 1B) rats. In BN rats, more virus
staining was visible inside the nerve fascicles, i.e. the endoneurium, the layer of connective tis-
sue surrounding the axons within the fascicle (arrowheads in Fig 1A). In both BN and SHR
rats HSV-1 was visualized in the perineurium, i.e. the layer of connective tissue surrounding
the nerve fascicles, in ring-like patterns similarly to those seen previously in the susceptible
Dark Agouti (DA) rats [8]. The activation of phagocytic cells in the whiskers area was similar
in both BN (Fig 1G) and SHR (Fig 1H) strains, with phagocytic cells penetrating into the nerve
fascicles.
HSV-1 entered the trigeminal ganglia infecting neuronal cell bodies in both the BN (Fig 1C)
and SHR (Fig 1D) rats. More virus staining was detected in the neuronal bodies of the BN rats,
although they remained asymptomatic. The virus concentration within the cluster of neuronal
cells possibly led to the visible disintegration in the neuronal morphology (Figs 1C, 1I and 2C)
compared to the neuronal morphology of SHR rats (Figs 1D, 1J and 2D). In the SHR rats HSV-
1 infected neurons did not degenerate, nor were ED1+ phagocytic cells in the vicinity of the
infected neuronal cell bodies activated in the same extent as in BN rats (Fig 1I and 1J). On the
other hand, more NK (Fig 2B) and CD8+ cells (Fig 2D) were visible in the trigeminal ganglia of
the SHR rats at this time point compared to the BN rats (Fig 2A and 2C).
The viral entry to the CNS was observed in both resistant and susceptible strains at the level
of the trigeminal nerve entrance at the ipsilateral side of the brain stem (Figs 1E, 1F and 2E–
2H; asterisks). In the brain stem of BN rats, most NKR+ cells lined the blood vessels and sur-
rounding tissue (Fig 2E; arrowheads), whereas in the SHR rats NKR+ cells were distributed in
the brain stem parenchyma (Fig 2F; arrowheads). However, a similar NKR+ cells infiltration
was observed inside the HSV-1 plaques. The distribution of CD8+ cells in the brain stem dis-
played a similar pattern to NK cells in both BN and SHR (Fig 2G and 2H; arrowheads).
Genetic analysis in the HXB/BXH RILs
The genetic determinants of rat HSE were identified using whole genome linkage analysis of
the HXB/BXH sets of RILs. The RILs were generated by crossing SHR and BN inbred strains to
obtain an F1 generation, which were then crossed with each other to generate an F2 generation.
Breeding pairs from the F2 generation were kept separately and bred consecutively by mating
siblings for 60 generations. Each of the generated and tested 29 lines had a unique set of
VWFGene Regulates HSE
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Fig 1. HSV-1 spread in the whiskers area, trigeminal ganglia, brain stem and ED1+ phagocytic cells
activation. Transversal/coronal sections from the whiskers area (A, B, G and H) and brain stem (E–F),
longitudinal/sagittal sections from the trigeminal ganglia (C, D, I and J) from HSV-1 infected BN and SHR
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recombinations separating them from the other lines [10]. The RILs responded differently to
HSV-1 infection mainly in incidence, onset of symptoms and days of survival (Fig 3). Five RILs
showed no symptoms of clinical disease and survived until 11 dpi, the experimental end point.
Twenty-four RILs presented with disease symptoms between 3 and 5 dpi, while the majority
died by 6 dpi (Fig 3). However, when monitoring the weight loss following infection as a sub-
phenotype, twenty RILs lost weight, seven RILs had an intermediate phenotype with variations
in the degree of weight loss and only two RILs were completely resistant to HSE and did not
lose weight at all after HSV-1 infection (Fig 3).
Genome-wide linkage analysis in RILs revealed a significant QTL,Hse6 regulating HSE inci-
dence on chromosome 4 which also correlated to weight loss (day 0 –day 10) (Fig 4A–4C).
This QTL is also suggestive for the regulation of onset of disease and the survival days after
infection. The confidence interval (CI) for the Hse6 is between Eno2 and D4Cebr9s4 markers
(160.89–174 Mb), with D4Utr41 (166 Mb) as the peak marker of QTL linkage. HSE susceptibil-
ity is linked to SHR alleles in this region (Fig 4B). A number of additional suggestive QTLs
were identified mainly on chromosome 4 for most of the studied phenotypes but also in several
other chromosomes. These QTLs include a suggestive QTL on chromosome 1 (CI: 94.3–109.3
Mb) for the survival days, a suggestive QTL on chromosome 9 (CI: 74.7–85.8 Mb) for the dif-
ference in weight loss between day 4 and day 5 and a suggestive QTL on chromosome 10 (CI:
12.0–16.7 Mb) for the incidence of disease and survival days. A summary of all the suggestive
QTLs that regulate HSE phenotypes detected in HXB/BXH RILs are presented in (S1 Table).
Searching for candidate genes in the Hse6QTL
To search for possible candidate genes inHse6 we prioritized significant sequence variants, dif-
ferentially expressed genes in eight tissues with cis-regulation (i.e. a cis-acting expression QTL
maps to the physical location of the gene itself [12, 23], and known immune regulatory func-
tions, in the vicinity of the QTL.
The Hse6 QTL found on chromosome 4 (160.89–174 Mb) associated to incidence of HSE
and correlated to weight loss (d0 –d10), harbors about 220 genes. Many of these genes are asso-
ciated with immune regulation, especially of NK (natural killer) cell and DC (dendritic cell)
regulation. This QTL includes a clusters of Klr (killer cell lectin-like receptor) genes, which are
NK cell receptor genes, Clec (C-type lectin family) genes, which are receptors on dendritic and
Langerhans cells as well as Ly-49 receptor genes, which are lectin-like (type II transmembrane
disulfide-bonded homodimers), expressed on NK cells and some T-cell subsets.
Comparison of the sequences of the BN and SHR rats in theHse6 (160.89–174 Mb) region
revealed 6,658 SNPs, 1,861 short indels (insertions/deletions) and 55 large deletions. Out of the
220 genes in this region only 21 genes showed non-synonymous coding variants, out of which
only four genes were also cis-regulated; Ncapd2 (ENSEMBL gene ID: ENSRNOG00000018771),
strains at 4dpi; stained for HSV-1 marker (green) (A–J), neuronal marker Tuj1 (red) (A–F) and the phagocytic
cell marker ED1 (red) (G–J). In the whiskers area, HSV-1 staining was seen in the epineurium of BN (A) and
SHR (B) rats, in the perineurial cell layer surrounding nerve fascicles (A and B; arrows) and in the
endoneurium of BN rats (A; arrowheads), while sporadically in SHR rats. In the trigeminal ganglia, HSV-1
spread was seen in both strains and was found in the neuronal cell bodies of BN (C; arrows) and SHR (D)
rats. However, in the BN rats the staining showed more affected neurons. In the brainstem, HSV-1 staining
could be seen mostly in processes surrounding the neurons (E; asterisk) and SHR (F; asterisk). Activation of
ED1+ phagocytic cells, in the whiskers area could be observed in BN (G) and SHR (H) rats. Phagocytic cells
were seen in close proximity to the nerves of the BN rats; whereas in the SHR stronger activation was
observed in the outer part of the epineurium (H) and less in the vicinity of the nerve. In the trigeminal ganglia,
activated ED1+ cells surrounding HSV-1 infected neuronal cell bodies were more visible in BN (I) compared
to SHR (J) rats. n = nerve. Scale bar: 50 μm = (A = B = C = D = E = F); (G = H = I = J).
doi:10.1371/journal.pone.0155832.g001
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Fig 2. HSV-1 activated NKR+ and CD8+ cells in the trigeminal ganglia and brain stem. Longitudinal/
sagittal sections of the trigeminal ganglia (A–D) and transversal/coronal sections from the brain stem (E–H)
from HSV-1 infected BN and SHR rats at 4dpi, stained for HSV-1 marker (green) (A–H), NK cell marker NKR
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Vamp1 (ENSEMBL gene ID: ENSRNOG00000019219), Vwf (ENSEMBL gene ID: ENSRNOG0
0000019689) and RGD1565709 (D3ZS19_RAT; ENSEMBL gene ID: ENSRNOG00000007247)
(Fig 5A). These 4 genes harbored non-synonymous SNPs and/or variants in putative splice site/
promoter region. Strikingly, of all the genes within the QTL, the Vwf of SHR origin was the
only gene that showed variants in the putative essential splice site (first 2 bps in two introns).
Vwf also harbored 3 SNP variants upstream of the gene, 2 non-synonymous coding variants;
Pro/Leu and Leu/Ser at position 30 and 748 in protein respectively and 18 synonymous variants
(S2 Table). To confirm the two non-synonymous variants and the essential splice site variants
in Vwf gene, we sequenced the region overlapping these variants in both SHR and BN using
(red) (A, B, E and F) and cytotoxic T cell marker CD8 (red) (C, D, G and H). In the trigeminal ganglia, NK cells
were less visible among the axons infected with HSV-1 in the resistant BN rats (A; arrowheads) compared to
the SHR rats (B; arrowheads). Also, fewer CD8+ cells were observed in BN (C; arrowhead) rats as compared
to the SHR (D; arrowheads). While in the brainstem, HSV-1 staining could be seen in both BN (E and G;
asterisk) and SHR (F and H; asterisk). NKR+ cells were less visible in BN rats (E; arrowheads) outlining the
blood vessels as well as cytotoxic CD8+ cells (G; arrowheads). In SHR rats, more NK cells (F; arrowheads)
and CD8+ (H; arrowheads) were present in the parenchyma. Scale bar: 50 μm = (A = B = E = F = G = H),
(C = D).
doi:10.1371/journal.pone.0155832.g002
Fig 3. Median values of measured phenotypes after HSV-1 infection in RILs. The table summarizes the median values of measured phenotypes in the
parental strains and the 29 RILs 10 days after HSV-1 infection. The table also includes the numbers of rats used from each parental strains and RILs, as well
as the number of dead rats from each line.
doi:10.1371/journal.pone.0155832.g003
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Fig 4. Linkage analysis in RILs reveals a significant QTL on chromosome 4 regulating incidence of HSE. (A) Genome-wide
linkage QTL map of HSE incidence. Linkage analysis revealed a significant QTL on chromosome 4 and additional suggestive QTLs
on chromosome 4 and 10. The upper x- axis shows rat chromosomes; lower x-axis shows physical map in mega bases and y-axis
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capillary sequencing by designing primers around ~200 bp on both sides of the variants. All
three variants were validated by capillary sequencing. In addition, the Vwf gene was cis-regu-
lated in 6 out of 8 tissues investigated, including the brain (Fig 5A). The p-values of the brain
Vwf gene cis-eQTLs were 2x10-4 and 0.006 respectively using two different probes (Fig 5B) [15].
For detailed exploration of the responsible genetic determinants for susceptibility to HSE a
haplotype map was determined in a set of different inbred rat strains. We have previously
found that the Lewis (LEW) and Fisher 344 (F344) rats were susceptible to HSE, where all rats
from both strains died at 5 dpi, while the Bio Breeding type 1 diabetic rats (BB) were resistant
and continued to gain weight after infection [9]. Using rat genome database (RGD) we
extracted a SNP haplotype map around Hse6 region (160–174 Mb; 77 SNPs tested), from dif-
ferent rat strains susceptible and resistant to HSE and additional colonies from some of these
strains, to which SNP information was available in RGD. Interestingly, only one marker
4:161682574 showed the same allele in all susceptible strains (DA, LEW, F344, SHR) and
another allele in all the resistant ones (PVG, BB, BN). The position of the marker
4:161,682,574 is approximately 40kb upstream to the Vwf gene. The flanking markers are
spaced 243,734 bp and 161,332 bp on each side and define a minimal haplotype region that is
spanning over 161,438,840–161,843,906 bp on chromosome 4 (Fig 5C, arrows). A critical
aspect for haplotype analysis is that genes elsewhere in the genome may convey resistance.
Therefore, the PVG rat was excluded from this haplotype analysis since it is possibly resistant
due to variants in the Calcr gene leading to lack of viral entry into the CNS [9]. However, the
sharing of the same marker in four susceptible strains and another allele in the resistant BB
and BN strains is interesting.
Within this minimal haplotype region only 3 genes were encoded, tumour necrosis factor
receptor superfamily member 3 (Ltbr, ENSEMBL gene ID: ENSRNOG00000019264), Amiloride-
sensitive sodium channel subunit alpha (Scnn1a, ENSEMBL gene ID: ENSRNOG00000019368)
and Vwf. Eight SNP variants were found upstream of the Ltbr gene, 14 SNPs were found 340–
4200 bp upstream of the Scnn1a gene and 3 were found 2677–4561 bp upstream of the Vwf gene.
One non-synonymous SNP variant located in a putative coding/splice site was found in Scnn1a
(transcript ENSRNOT00000026320) and in Vwf, one non-synonymous coding variant was
found in exon 2 and one in exon 17, but none in Ltbr. Vwf also harbors a SNP variant located at
the putative essential splice site for exon 6.
VonWillebrand factor (vWF) protein expression in BN and SHR tissues
Considering all the findings in this study, Vwf was the main candidate gene for regulating the
difference in susceptibility to HSE between the studied rat strains. Using immunohistochemis-
try we assessed staining differences in vWF expression in HSV-1 infected BN and SHR rats
(Fig 6A). The vWF protein is synthesized in the endothelial cells and is stored in intracellular
granules. vWF functions in the blood coagulation system as platelets adhesion molecule and
anti-haemophilic factor carrier in vessel walls, having a role in hemostasis [24]. In addition, it
has also been suggested to have a role in maintaining the blood-brain barrier hemostasis [25].
represents linkage in LRS (likelihood ratio scores) score. Upper red horizontal line: significant LRS genome-wide threshold at
P 0.05. Lower grey horizontal line: suggestive LRS genome-wide threshold at P 0.63. WebQTL used to generate the graph. (B)
Interval QTL maps with bootstrap analysis of chromosome 4 QTLs for HSE incidence. Yellow-histogram: frequency of peak LRS
(bootstrap analysis). The green trace indicates that the SHR allele increase the trait values (positive additive coefficient). WebQTL
used to generate the graph. (C) Summary of HSE phenotypes, which are regulated in the Hse6QTL in the RILs. Values represent
LRS for main effect QTLs. Significance thresholds were generated with 1000 permutations and 1000 bootstraps. The peak marker
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Fig 5. Vwf gene is cis-regulated in the brain and haplotypemapping revealed aminimal haplotype region. (A) Cis-regulated expression
QTLs withinHse6 from naïve tissues of RILs. Abbreviations: adr—adrenal gland; kdn—kidney; lv–left ventricle; skm—skeletal muscle. (B) Vwf is
significantly cis-regulated in the brain eQTL, LRS >40. Upper red horizontal line: significant LRS genome-wide threshold at P 0.05. Lower blue
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In the whiskers area and in the brain stem of BN rats, vWF staining clearly delineated the
large blood vessels and capillaries (Fig 6A(I), 6A(III) and 6A(V); arrows). However, in the SHR
rat vWF staining was less visible around the blood vessels (Fig 6A(II), 6A(IV) and 6A(VI),
arrows). In parallel, we stained the tight junction protein, occludin as a marker for endothelial
cells and the BBB (blood brain barrier) to assess its integrity in BN and SHR rats after HSV-1
infection. In the brain stem of both strains, the occludin staining outlined the larger blood ves-
sels with no visible difference between these two strains, indicating that there were no major
differences in the staining of the tight junctions in the two strains (S1 Fig).
To quantify the vWF expression in BN and SHR rats we performedWestern Blot on naive
brain lysates and vessel-rich lungs as controls. In both tissues, the BN rats displayed a signifi-
cantly higher expression of vWF compared to SHR (Fig 6B and 6C). Thus, the Western Blots
support the assessment of higher vWF expression in BN rats observed in histological staining
of brain sections.
rs917859 SNP within the VWF gene is associated with human HSE
To investigate the association of VWF gene to human HSE disease, we genotyped 27 SNPs
within the VWF gene and one SNP within the TNFRSF1A adjacent gene located on chromo-
some 12 using Taqman in 115 HSE cases and 158 EIMS (epidemiological investigation of mul-
tiple sclerosis project) controls [20]. In the analysis, we also included 217 EIMS MS cases and
211 EIMS controls that were serum positive to HSV-1 infection. We found a nominal associa-
tion with the SNP rs917859 (5.95 Mb) with odds ratio (OR) of 1.5 (p-value = 0.008) (Table 1).
Interestingly, the association seems to be of a recessive pattern (S3 Table). This SNP is located
within the intronic region between exon 43 and 44 of the VWF gene. We tested haplotype asso-
ciation between rs917859 and the adjacent markers (Table 2) in which the rs917859 –
rs4764521 GG haplotype was slightly more significantly associated (p-value = 0.004) to HSE
than the rs917859 marker alone.
Additionally, we genotyped 6 SNPs within the intronic region between exon 43 and 44 that
showed association in all HSE cases and the 158 EIMS controls. We identified association to
HSE with more SNPs in this region, especially rs2239138 and rs12829271 with OR of 1.6 (p-
value = 0.06) (Table 3). Haplotype association for these new markers and rs917859 generated
similar p-values as for single markers (data not shown). Also, all the analysis was performed
including more HSE cases and controls of non-Scandinavian origins. The association was
mapped to the same SNP variants with increased significance (Fig 7, Tables 1–3).
In conclusion, the association of human VWF SNP variants to HSE in this region, and thus
the confirmation of the rat data, further supports the novel association of VWF to HSE.
Discussion
HSE, although rare, remains the most common cause of acute sporadic viral encephalitis in the
western world [26]. Despite the adequate use of antiviral treatment, the mortality and morbid-
ity remains high and therefore dissection of the pathogenic factors is warranted. The key find-
ings of the current study point to genetic variants of the VWF gene, together with expression
horizontal line: suggestive LRS genome-wide threshold at P 0.63. (C) SNP haplotype map of the tested HSE susceptible and resistant inbred
strains and additional not tested sub-colonies of some strains (PVG/seac; BN/NHsdMcw; SHR/NHsd; SHR/Ncrl; DA/Slc; DA/OlaHsd). Within the
Hse6 region, 77 SNPs were found in RGD. Here we present the map with only 42 SNPs (between 160–165 Mb), in which the arrows point
towards the only SNPmarker position that showed the same allele in all resistant strains (blue allele) and a different allele in all susceptible strains
(red allele). The flanking markers define a minimal haplotype region regulating HSE that is spanning over 161,438,840–161,843,906 bp on
chromosome 4 indicating the influence of Vwf gene.
doi:10.1371/journal.pone.0155832.g005
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Fig 6. Less expression of vWF in the brain of SHR rats. (A) Transversal/coronal sections from the whiskers area (I and
II) and the brain stem (III–VI) of BN (I, III and V) and SHR (II, IV and VI) rats at 4dpi, stained with vWF Ab (green) (I–VI), NK
cell marker NKR (red) (I–IV). Distinct staining of vWF could be observed in the whiskers area (I; arrow) and the brain stem
(III; arrow) of the BN rats with a limited spread of NK cells (I and III; arrowheads) compared to SHR. In SHR, lower and
more fragmented staining of vWF (II and IV; arrows) could be observed with more abundant influx of NK cells both in the
whiskers area (B; arrowheads) and brain stem parenchyma (IV; arrowheads). vWF staining was visible in the brain stem of
the BN rats outlining capillaries (V; arrows). While in the SHR rats was reduced and fragmented in the larger vessels (IV
and VI; arrows) and absent in the small capillaries (VI). Scale bar: 50 μm = (I = II = III = IV); (V = VI). (B) vWF expression
assessed byWestern Blot: The image displays representative samples from naïve lung and brain tissues from BN and
SHR rats. The expression of vWF was more abundant and significantly higher in the lungs as compared to brain tissues in
both strains. SHR strain displayed reduced levels of vWF in both tissues compared to BN. Actin served as a loading
control. (C) Quantification of vWF expression assessed usingWestern Blot: We quantified the vWF expression from bands
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above 200kDa and normalized the signal to the respective actin controls. The data includes quantifications from 3–4 naïve
rats/group. In both tissues, BN rats had a significantly higher vWF expression compared to SHR as analysed by Student’s
T-test (*: p<0.05, **p<0.01).
doi:10.1371/journal.pone.0155832.g006
Table 1. Summary of VWF SNPs analysis and association in HSE cases and EIMS controls.
Scandinavian All individuals
Marke Position Minor allele MAF cases MAF controls HWE P controls OR (95% CI) P-value OR (95% CI) P-value
rs2885517 5920581 tagged 0.61 0.58 0.79 0.26 1.12 0.44
rs2270151 5931221 A 0.1282 0.1585 0.869 0.77 (0.50–1.19) 0.24 0.78 (0.51–1.19) 0.2461
rs2286646 5931752 G 0.2155 0.2165 0.1159 1.04 (0.73–1.49) 0.81 0.99 (0.70–1.41) 0.9729
rs12317523 5933403 A 0.2564 0.2579 0.7291 0.96 (0.69–1.35) 0.82 0.99 (0.72–1.37) 0.9632
rs723188 5934166 A 0.1838 0.1627 0.03447 1.27 (0.87–1.86) 0.21 1.16 (0.80–1.68) 0.4363
rs12368267 5941777 G 0.09322 0.1063 0.4879 0.91 (0.57–1.49) 0.70 0.86 (0.53–1.40) 0.553
rs11063961 5944277 G 0.1907 0.187 0.0403 1.00 (0.69–1.45) 0.98 1.02 (0.71–1.47) 0.8965
rs12300917 5949319 A 0.1496 0.1903 0.08273 0.80 (0.54–1.21) 0.29 0.75 (0.51–1.11) 0.1458
rs917857 5952085 A 0.4153 0.4783 0.6567 0.75 (0.55–1.09) 0.05 0.77 (0.58–1.03) 0.0806
rs917859 5952374 A 0.4231 0.3287 0.3659 1.50 (1.11–2.02) 0.008 1.50 (1.12–2.00) 0.006253
rs4764521 5954584 A 0.2542 0.2126 0.5962 1.27 (0.91–1.79) 0.16 1.26 (0.91–1.76) 0.1645
rs216883 5967918 A 0.2974 0.2638 0.5678 1.13 (0.82–1.57) 0.45 1.18 (0.86–1.62) 0.2978
rs216889 5969714 A 0.4873 0.4882 0.4787 0.99 (0.74–1.33) 0.92 1.00 (0.75–1.32) 0.9801
rs17491334 5974105 A 0.08547 0.1201 0.6792 0.73 (0.44–1.20) 0.21 0.68 (0.42–1.12) 0.1326
rs216904 5976279 tagged 0.43 0.39 0.73 0.21 1.15 0.33
rs216312 5999245 A 0.4545 0.4803 0.6567 0.93 (0.68–1.25) 0.62 0.90 (0.67–1.21) 0.4877
rs11611917 6006895 A 0.2119 0.252 0.9062 0.86 (0.60–1.23) 0.42 0.80 (0.57–1.12) 0.1965
rs216338 6018587 A 0.3559 0.378 1 0.95 (0.70–1.29) 0.74 0.91 (0.68–1.22) 0.5288
rs980130 6039288 A 0.3008 0.3278 0.1067 0.87 (0.63–1.19) 0.39 0.88 (0.65–1.20) 0.4257
rs980131 6039459 tagged 0.39 0.42 0.84 0.29 0.86 0.33
rs4764482 6039994 G 0.5388 0.4901 0.01605 0.82 (0.61–1.11) 0.20 1.22 (0.91–1.62) 0.1808
rs12319392 6040747 A 0.07203 0.08858 1 0.86 (0.50–1.50) 0.60 0.80 (0.47–1.37) 0.4127
rs2283332 6044990 A 0.09402 0.09055 1 1.00 (0.60–1.67) 0.98 1.04 (0.64–1.70) 0.8681
rs3782711 6053442 G 0.1154 0.1181 0.8313 1.00 (0.64–1.58) 0.99 0.97 (0.62–1.52) 0.9071
rs2238104 6057926 A 0.5042 0.4419 0.02437 1.32 (0.98–1.77) 0.06 1.28 (0.97–1.71) 0.08327
rs2239144 6066444 tagged 0.10 0.13 0.71 0.17 0.80 0.34
rs2239140 6070704 A 0.4872 0.4557 0.0897 1.15 (0.86–1.55) 0.35 1.14 (0.85–1.51) 0.384
rs11064024 6072310 G 0.3771 0.3984 0.3089 0.96 (0.71–1.30) 0.81 0.92 (0.68–1.22) 0.5464
rs11836843 6073079 G 0.06356 0.06496 0.7128 0.98 (0.55–1.78) 0.97 0.98 (0.55–1.74) 0.9372
rs1860545 6317038 A 0.4103 0.4341 0.1765 0.93 (0.69–1.26) 0.65 0.91 (0.68–1.21) 0.5073
MA = minor allele; MAF = minor allele frequency; HWE = Hardy-Weinberg Equilibrium; OR = odds ratio; CI = conﬁdence interval.
Success rate for each marker in cases and controls was between (98–100%). Chr12 SNPs positions (in bp) (Genome build 36.3).
Tagging with two or three markers was used for 4 markers: rs2885517 was tagged by the rs2270151 A—rs12317523 G haplotype;
rs216904 was tagged by the rs17491334 A—rs216889 G haplotype; rs980131 was tagged by the rs12319392 C—rs4764482 A haplotype and rs2239144
was tagged by the rs2238104 C—rs2239140 G -rs11064024 A haplotype.
Scandinavian columns: represent analysis of OR and P-value made in Scandinavian 115 HSE cases and 428 EIMS controls;
All individuals columns: represent analysis of OR and P-value made in Scandinavian and non-Scandinavian 119 HSE cases and 508 EIMS controls.
doi:10.1371/journal.pone.0155832.t001
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differences as a novel risk for HSE development. Though first identified in young adult rats as
one main candidate factor determining HSE susceptibility, the findings were replicated in a
human case-control cohort and several variants in the VWF gene were nominally associated
with HSE.
We studied HSE pathogenesis using an experimental animal model. HSV-1 was detected in
the whiskers area, trigeminal ganglia and the brain stem in both BN and SHR strains. The pres-
ence of the virus in the parenchyma of resistant BN rats oppose our previous findings in the
resistant PVG rats, in which HSV-1 did not penetrate the CNS [7]. In mice, a similar phenome-
non of infection has been described earlier in both resistant and susceptible strains [27]. In
spite of the viral spread to the trigeminal ganglia in both rat strains a more pronounced infec-
tion and phagocytic activation was observed in the neurons of the resistant BN rats. However,
in the susceptible SHR strain more NK and CD8+ cells were visualised indicating a possibly
Table 2. Haplotype association between rs917859 and the two adjacent markers.
Scandinavians All individuals
Marker combination Haplotype Frequency cases Frequency controls OR P-value OR P-value
rs917857—rs917859 GA 0.42 0.33 1.49 0.008 1.51 0.006
AG 0.41 0.48 0.75 0.05 0.78 0.08
GG 0.16 0.19 0.87 0.43 0.82 0.24
rs917859—rs4764521 AA 0.12 0.10 1.48 0.21 1.43 0.17
GA 0.13 0.12 1.15 0.60 1.16 0.53
AG 0.30 0.23 1.43 0.04 1.45 0.03
GG 0.45 0.56 0.63 0.004 0.62 0.003
OR = odds ratio
Scandinavian columns: represent analysis of OR and P-value made in Scandinavian 115 HSE cases and 428 EIMS controls;
All individuals columns: represent analysis of OR and P-value made in Scandinavian and non-Scandinavian 119 HSE cases and 508 EIMS controls.
doi:10.1371/journal.pone.0155832.t002
Table 3. Summary of additional VWF SNPs analysis and association in 115 HSE cases and 158 EIMS controls.
Scandinavian All individuals
SNP marker Position Minor Allele MAF cases MAF controls OR (95% CI) P-value OR (95% CI) P-value
rs12369177 5943781 T 0.404 0.366 0.97 (0.65–1.43) 0.86 1.18 (0.81–1.70) 0.39
rs11063961 5944277 G 0.191 0.187 1.00 (0.69–1.45) 0.98 1.02 (0.71–1.47) 0.90
rs12300917 5949319 A 0.149 0.190 0.80 (0.54–1.21) 0.29 0.75 (0.51–1.11) 0.15
rs7301070 5950551 G 0.423 0.314 1.46 (0.98–2.16) 0.06 1.61 (1.11–2.33) 0.01
rs2238110 5950838 G 0.423 0.314 1.46 (0.98–2.16) 0.06 1.61 (1.11–2.33) 0.01
rs917857 5952085 A 0.415 0.478 0.75 (0.55–1.00) 0.05 0.77 (0.58–1.03) 0.08
rs917858 5952199 C 0.423 0.316 1.43 (0.97–2.13) 0.07 1.59 (1.09–2.30) 0.01
rs917859 5952374 A 0.423 0.329 1.50 (1.11–2.02) 0.008 1.50 (1.12–2.00) 0.006
rs2239138 5952819 A 0.427 0.314 1.46 (0.98–2.16) 0.06 1.63 (1.13–2.37) 0.009
rs12829271 5953060 A 0.427 0.314 1.46 (0.98–2.16) 0.06 1.63 (1.13–2.37) 0.009
rs4764521 5954584 A 0.254 0.213 1.27 (0.91–1.79) 0.16 1.26 (0.91–1.76) 0.16
MAF = minor allele frequency; HWE = Hardy-Weinberg Equilibrium; OR = odds ratio; CI = conﬁdence interval. (Chr12 SNPs positions (in bp) (Genome
build 36.3). Table summarizing the analysis of the new 6 and 3 associated SNPs (the analysis was run in a total of 36 SNPs, data not shown).
Scandinavian columns: represent analysis of OR and P-value made in Scandinavian 115 HSE cases and 428 EIMS controls;
All individuals columns: represent analysis of OR and P-value made in Scandinavian and non-Scandinavian 119 HSE cases and 508 EIMS controls.
doi:10.1371/journal.pone.0155832.t003
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Fig 7. Illustration of VWF SNPs positions, linkage disequilibrium and association to HSE. (A) Association was
tested in Scandinavian and non-Scandinavian 119 HSE patients and 508 control individuals positive for HSV-1 IgG
antibodies. Evidence of association is plotted as the negative logarithm to the base 10 of the p-value of allelic association
against position in base pair along chromosome 12. The association was estimated using the assoc and hap-assoc (for
aggressively tagged markers) commands in PLINK. The genomic build used was 36.3. (B) Linkage disequilibrium (LD)
measured by r2 between markers included in the association analysis. The LD was estimated in Haploview 4.2 using
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stronger cytotoxic immune reaction at 4 dpi, which subsequently may contribute to the devel-
opment of disease symptoms in this strain. This is in line with the previously published results
indicating a combined role of NK and CD8+ cells in regulating virus spread in the HSE resis-
tant C57BL/6 mice [28]. However, the difference in immune responses detected in our studied
strains could also be due to variants in immune related genes and not exclusively linked to the
identified variants in the Vwf gene. Additional studies will be needed to dissect these differ-
ences and understand the exact mechanism of disease. It has previously been reported in paedi-
atric case studies that impaired production of type I interferons (IFN) via the toll-like receptor
3 (TLR3) pathway were involved in HSE susceptibility. In these cases the influence was attrib-
uted mainly to genetic polymorphisms in UNC93B1 [29]and TLR3 genes [30]. Also, a number
of studies using different HSE mice models and/or reverse genetics approaches point to the
influence of different immune cells, cytokines and chemokines in viral reactivation and disease
outcome [31–34]. Altogether, these findings support the notion of a role of immune genes in
disease pathogenesis. Additionally, from our previous findings in rat, we identified Calcr as a
candidate for HSE susceptibility in DA and PVG strains [9] suggesting the involvement of mul-
tiple genes in HSE regulation.
In our study, the use of genome wide linkage analysis unraveled the genomic region Hse6
regulating HSE.Hse6 harbors a number of immune-related genes, which might have relevance
in the susceptibility to/protection against HSE development such as the NK and dendritic cell
receptor genes. An earlier study in mice identified a natural killer (NK) complex-linked locus,
Rhs1 (resistance toHerpes simplex virus 1), on mouse chromosome 6 that controls resistance to
acute and latent HSV-1 infections [35]. However, our sequencing and expression data com-
bined with the haplotype analysis narrowed down the numerous candidates in Hse6 to the Vwf
gene. Additionally, the study by Lundberg and colleagues identified in a mouse model of cor-
neal HSV-1 infection a second locus on chromosome 6,Hrl (Herpes resistance locus) to influ-
ence survival to HSV-1 infection in C57BL/6J. The relatively large confidence interval ofHrl
contains many genes, including the Tnfrsf1a gene suggested as a candidate for resistance in the
mouse species [36], which is located in close proximity to the Vwf gene highlighted in our
study. Recently, another study using a different model in mice maps between Cd69 and
D6Wum34, to a segment separate from the previous mice QTLs that also consists of NK com-
plex-linked locus that confers resistance to HSV-1 infection of the brain [37]. Thus, all the
regions described in mice restrict viral spread to the CNS and correspond to the sameHse6
region in rat. Interestingly, the co-localization of the QTLs both in rats and mice provide an
additional support to the influence of this region on the HSE pathogenesis in rodents and the
importance of NK cells for anti-viral responses.
The exact role of Vwf variants on HSE susceptibility still remains to be understood and fur-
ther mechanistic studies are needed. The vWF is a large glycoprotein found in blood plasma,
platelet α-granules, endothelial cells and subendothelial connective tissue. The vWF protein
has an important role in hemostasis, regulating the adhesion of platelets and the binding of fac-
tor VIII [24]. In this study, our immunohistochemical stainings indicated less abundant vWF
around blood vessels in the susceptible SHR strain, which was supported by quantification of
the protein using Western Blot. The reduced expression may be attributed to the SNP variants
in the Vwf gene. Since the expression of vWF is reduced in the HSE susceptible SHR strain, we
genotypes from 119 HSE patients and 508 individuals positive for HSV-1 IgG antibodies. (C) Association plot including
the additional 6 SNPs tested in 119 HSE patients and 158 EIMS controls positive for HSV-1 IgG antibodies. Evidence of
association is plotted as the negative logarithm to the base 10 of the p-value of allelic association against position in base
pair along chromosome 12.
doi:10.1371/journal.pone.0155832.g007
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speculate a possible dysregulation in the CNS endothelial cell layer. This could lead to an
increased vascular permeability or alternative mechanisms in SHR rats leading to more infiltra-
tion of immune cells into the CNS after HSV-1 infection. Also, we previously published, using
a rat heterogeneous stock (HS) composed of eight different outbred rat strains, that Vwf was
the main gene in a locus regulating platelet aggregation. This further indicates that the presence
of variations within the Vwf gene in different rat strains is likely to contribute in influencing
additional phenotypes [38]. It has been reported previously when using Vwf knockout mice in
an experimental autoimmune/allergic encephalomyelitis (EAE) model for Multiple Sclerosis
(MS), that vWF influences the permeability of the blood brain barrier (BBB) leading to
increased infiltration of inflammatory cells into the CNS [39]. The interaction between differ-
ent viruses and BBB cells causing increased permeability and cellular infiltration has been pro-
posed in a number of studies, even though the exact mechanisms are not yet well defined. This
has be shown after infections with West Nile virus (WNV) [40, 41], Japanese encephalitis virus
(JEV) [42], rabies virus [43] and HIV [44]. In line with these findings, HSV-1 infection in the
CNS could possibly cause a disruption of the endothelial BBB lining entailing increased cellular
infiltration through VWF dependent or independent mechanisms. Notably, in the plasma of
cerebral malaria patients the release of increased levels of vWF has been reported after Plasmo-
dium falciparum infection [45–48]. Together, this highlights a role of vWF after infection with
different pathogens particularly in the CNS.
We believe that our finding of a nominal association of the VWF gene to human HSE dis-
ease is of clinical interest and may be translated to predictive markers. Interestingly, the data
also suggest a recessive pattern of inheritance. A replication of the association in a larger and
independent cohort would be desirable and of value for future studies. Furthermore, mechanis-
tic studies of vWF and the interplay with immune-related genes that govern HSE susceptibility
are required.
Conclusions
Our work identified Vwf as a candidate for HSE regulation in rat. Although HSV-1 was spread
to the CNS of both rat strains used, only the susceptible SHR strain showed more NK cell infil-
tration. Notably, the expression of vWF was reduced in the susceptible strain. We also investi-
gated an involvement of VWF in human HSE by the nominal association of several SNP
variants. Collectively, these data implicate the importance of controlling cell activation and
infiltration during neuroinflammation and neuropathogenesis of HSE. The mechanisms
underlying HSE need to be further explored in relation to allelic variants of VWF and other
risk genes discovered in rodents models and humans.
Supporting Information
S1 Fig. Similar occludin staining in the blood vessels of the brain stem of both strains.
Transversal/coronal sections from the brain stem of BN (A, B, C, G, H and I) and SHR (D, E,
F, J, K and L) rats stained with HSV-1 Ab (green) (A, C, D and F), occludin (tight junctions
marker) (red) (B, C, E, F, H, I, K and L) and vWF marker (green) (G and J). The HSV-1 spread
was seen in the brain stem of the resistant BN rats (A and C; asterisks) and the susceptible SHR
(D and F; asterisks). vWF protein was found in the large vessels and capillaries of BN rats in
the brain stem (G and I; arrowheads and arrow) while in the SHR rats vWF staining was only
visible in the larger vessels (J and L; arrowheads). Occludin staining of the tight junctions was
similar in the brain stem of both BN (B, C, H and I; arrows) and SHR (E, F, K and L; arrows)
rats. Scale bar: 50 μm.
(TIF)
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S1 Table. Summary of identified suggestive QTLs that regulate HSE phenotypes in RILs.
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